glp-1 injections compounded semaglutide Weight Loss Options Switching from a compounded to

Formulation also plays a role

Large study shows benefits and harms of GLP-1s in people with diabetes January 27, 2025 Source: Xie, et al, Nature Medicine, January 20, 2025 Researchers published a comprehensive review of electronic medical records from the Veterans Administration (VA) to demonstrate the benefits and harms of GLP-1 medications

Another serious but less common cause is a condition known as Small Intestinal Bacterial Overgrowth (SIBO)

Traditional high-calorie snacking categories and center-store products are seeing reduced consumption, slowing growth for portfolios heavily indexed to these areas

Over the last decade, sodiumglucose cotransporter-2 inhibitors, glucagon-like peptide 1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists have emerged as potent kidney-protective and/or cardioprotective agents in type 2 diabetes